SCHEMBL28828748

SCHEMBL28828748

COc1ccc(-c2ccc3c(c2)CC(C)(C)C3OC(N)=O)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 0.42
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.36
HSP90AA1 P07900 2/20 0.35
EIF4E P06730 1/20 0.35
TDP2 O95551 1/20 0.34
DYRK1A Q13627 1/20 0.34
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
BTK Q06187 2/20 0.34
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
TAS1R2 Q8TE23 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29121279 1.00 FASN (0.42) FASNPDK1PDK2PDK3PDK4
SCHEMBL28828431 0.92 RORC (0.37) FASNPDK1PDK2PDK3PDK4
SCHEMBL29121214 0.90 FFAR4 (0.36) FASNPDK1PDK2PDK3PDK4
SCHEMBL29228309 0.90 FASN (0.43) FASNPDK1PDK2PDK3PDK4
SCHEMBL28828676 0.89 CYP1A1 (0.45) SMN1; SMN2TDP2CYP1A2CYP2D6CYP2C9
SCHEMBL29121245 0.89 FASN (0.33) FASNPDK1PDK2PDK3PDK4
SCHEMBL29121351 0.89 FFAR1 (0.40) FASNPDK1PDK2PDK3PDK4
SCHEMBL28828394 0.88 DYRK1A (0.36) SMN1; SMN2TDP2DYRK1APRMT5WDR77
SCHEMBL28828754 0.88 AKR1C3 (0.38) SMN1; SMN2CYP2C19
SCHEMBL29121265 0.88 AKR1C3 (0.38) SMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114829361-B Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same 柳韩洋行 2024-07-16 CN claimed
CN-114829361-A Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing same 柳韩洋行 2022-07-29 CN claimed
CN-114829361-B Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same 柳韩洋行 2024-07-16 CN disclosed
CN-114829361-A Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing same 柳韩洋行 2022-07-29 CN disclosed